Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title Principal Investigator Post Date
5-Cog Battery to Improve Detection of Cognitive Impairment and Dementia (5-COG) Joe Verghese, MD   
A 12-Month, Open-Label, Repeat-Dose Safety Study of NRL-1 in Epilepsy Subjects Alexis Boro, MD   
A 24 Week, Multicenter, Randomized, Double-Blind, Parallel Group, Phase 3 Trial with a 28 Week Long Term Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 10 mg in T2DM Patients aged 10-24 years. Rubina Heptulla   
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease (TARGET-IBD) Gitit Tomer, MD   
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH) Bryan Rudolph, MD   
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients (BRIGHT 1012) Amit Verma, MD   
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension Nicole Sutton   
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF) Jooyoung Julia Shin, MD   
A Feasibility and Biomarker Study to Evaluate Necitumumab in the Neoadjuvant Setting With Gemcitabine and Cisplatin in Surgically Resectable Squamous Lung Cancer Balazs Halmos, MD   
A Long-Term, Open-Label Follow-up Study of Tofacitinib for Treatment of Juvenile Idiopathic Arthritis (JIA) Dawn Wahezi, MD   
A multi-center prospective study to evaluate the safety and effectiveness of the VasQ external support for arteriovenous fistula Stuart Greenstein, MD   
A Multi-center, Randomized Controlled Study of the Vertos MILD Procedure With Conventional Medical Management Versus Conventional Medical Management Alone in the Treatment of Lumbar Spinal Stenosis (The MOTION Study) Sayed Wahezi, MD   
A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study With Randomized Withdrawal and Retreatment to Evaluate the Efficacy and Safety of BMS-986165 in Subjects With Moderate-to-Severe Plaque Psoriasis Holly Kanavy, MD   
A Multi-Center, Randomized, Placebo Controlled, Double-Blind Study to Confirm Efficacy and Safety of Terlipressin in Subjects With Hepatorenal Syndrome Type 1 (The CONFIRM Study) Samuel Sigal, MD   
A Multi-center, Randomized, Placebo-controlled, Double-blind, Adaptive Clinical Trial of Vitamin C, Thiamine and Steroids as Combination Therapy in Patients With Sepsis Michelle Gong, MD   
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications David Loeb, MD   
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients David Loeb, MD   
A Multicenter, Double-Blind, Parallel-Arm, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM 3) Paul Riska, MD   
A Multicenter, Open-Label, Phase 1B/2 Study to Evaluate Safety and Efficacy of Avelumab (MSB0010718C) IN COMBINATION WITH Chemotherapy With Or Without Other Anti-Cancer Immunotherapies as First-Line Treatment In Patients With Advanced Malignancies Balazs Halmos, MD   
A Multicenter, Open-label, Randomized, Event-driven Study to Assess Efficacy, Safety and Pharmacokinetics of Macitentan Versus Standard of Care in Children With Pulmonary Arterial Hypertension (PAH) (TOMORROW) Nicole Sutton, MD   
A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma (CLEAR) Benjamin Gartrell, MD   
A Multicenter, Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study of BB3 to Reduce the Severity of Delayed Graft Function in Recipients of a Deceased Donor Kidney Enver Akalin, MD   
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis. Samuel Sigal, MD   
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis Joann Kwah, MD   
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata Steven Cohen, MD   
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Subjects With Active Systemic Lupus Erythematosus Chaim Putterman, MD   
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER) Sanjay Goel, MD   
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias Noah Kornblum, MD   
A Phase 1, Open-Label, Non-Randomized, Safety, Tolerability and Pharmacokinetic Study of TAS3681 in Patients With Metastatic Castration Resistant Prostate Cancer Benjamin Gartrell, MD   
A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) (ZUMA-1) Ira Braunschweig, MD   
A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies Sanjay Goel, MD   
A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Sanjay Goel, MD   
A Phase 1b Study to Assess the Safety, Tolerability, and Clinical Activity of BGB-290 in Combination with Temozolomide (TMZ) in Subjects with Locally Advanced or Metastatic Solid Tumors Sanjay Goel, MD   
A Phase 1b/2, Open-Label, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of SM88 in Patients With Prostate Cancer Benjamin Gartrell, MD   
A Phase 1b/2a, Multi-Center Open-Label Study to Evaluate the Safety and Efficacy of Combination Treatment With MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients With Recurrent/Metastatic HPV Associated Head and Neck Squamous Cancer Balazs Halmos, MD   
A Phase 2 Open-Label, Randomized Study of PARP Inhibition (Olaparib) Either Alone or in Combination With Anti-PD-L1 Therapy (Atezolizumab; MPDL3280A) in Homologous DNA Repair (HDR) Deficient, Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer Jesus Anampa Mesias, MD   
A Phase 2 Study of Poziotinib in Patients With Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, With EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20) Haiying Cheng, MD   
A Phase 2 Study of the Safety, Tolerability, and Efficacy of Parsaclisib in Combination With Ruxolitinib in Subjects With Myelofibrosis Swati Goel, MD   
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis (AD) Holly Kanavy, MD   
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess Safety and Efficacy of Topically-applied AG013 for the Attenuation of Oral Mucositis in Subjects w/Cancers of Head and Neck Receiving Concomitant Chemoradiation Therapy Madhur Garg, MD   
A Phase 2, Open-Label Study of Parsaclisib in Participants With Autoimmune Hemolytic Anemia Irina Murakhovskaya, MD   
A Phase 2, Randomized, Double-Blind, Dose-Ranging Study to Determine the Pharmacokinetics, Safety and Tolerability of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease John Thompson, MD   
A Phase 2b/3 Prospective, Randomized, Double-Blind, Sham-Controlled Trial of VTS-270 (2-hydroxypropyl---cyclodextrin) in Subjects with Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease Paul Levy   
A Phase 3 Randomized Study Comparing Perioperative Nivolumab vs. Observation in Patients With Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC) Benjamin Gartrell, MD   
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Patients w/Influenza A Infection Paul Riska, MD   
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis Holly Kanavy, MD   
A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer Benjamin Gartrell, MD   
A Phase 3 Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Subjects With Advanced Urothelial Cancer and Selected FGFR Gene Aberrations Benjamin Gartrell, MD   
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis Samuel Sigal, MD   
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (REVERSE) Samuel Sigal, MD   
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome Anna Bortnick, MD   
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis Thomas Ullman, MD   
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine (Advance) Richard Bruce Lipton, MD   
A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant Deepa Manwani   
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion (Cadenza Study) Irina Murakhovskaya, MD   
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes Rubina Heptulla   
A Phase 3, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus-Eluting Collagen Implant Larry Scher, MD   
A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) Anna Zolotnitskaya, MD   
A Phase I-II Study of PTX-200 Plus Sequential Weekly Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide in Patients With Metastatic and Locally Advanced Breast Cancer Joseph Sparano, MD   
A Phase I/II Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Fulvestrant in Subjects With HR+/HER2- Advanced or Metastatic Breast Cancer Sun Young Oh, MD   
A Phase I/IIa, Open Label, Dose-escalation Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy Sanjay Goel, MD   
A Phase II Multi-Center, Randomized, Double-Blind, 24-Week, Parallel Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Children and Adolescents Age 5-17 With Autism Spectrum Disorder (ASD) Eric Hollander, MD   
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases Caterina Minniti, MD   
A Phase II Study of MLN0128 (TAK-228) in Rapalog-Resistant Advanced Pancreatic Neuroendocrine Tumors (PNET) Lakshmi Rajdev, MD   
A Phase II Trial Assessing the Tolerability of Palbociclib in Combination With Letrozole or Fulvestrant in Patients Aged 70 and Older With Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer Jesus Anampa Mesias, MD   
A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Platinum-Ineligible Patients with Unresectable Stage IV Urothelial Cancer Benjamin Gartrell, MD   
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid Lisa Gennarini, MD   
A Phase WW Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody Ch14.18 (Dinutuximab, NSC764038, IND 4308) in Combination with Sargramostim (GM-CSF) in Patients with Recurrent Osteosarcoma. Lisa Figueiredo   
A Pilot Presurgical Trial of Insulin Inhibition by a Ketogenic Diet in Operable Breast Cancer Eugene Fine, MD   
A Pilot Study to Assess the Role of Cannabis Added to the Supportive Care Regimen During Chemoradiation for Head and Neck Cancer Rafi Kabarriti, MD   
A Prospective Clinical Evaluation of the DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation Luigi Di Biase, MD, PhD   
A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Extended-release/Long Acting (ER/LA) Opioids for the Treatment of Chronic Pain Joanna Starrels, MD   
A Prospective Observational Study of Adult Patients Receiving DUPIXENT® for Atopic Dermatitis Holly Kanavy, MD   
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam®/Kolbam® (Cholic Acid) Nadia Ovchinsky, MD   
A Randomized Phase II Clinical Trial Assessing the Efficacy and Safety of MK-3475 (Pembrolizumab) in Combination With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer Sun Young Oh, MD   
A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women With Recurrent, Persistent or Metastatic Endometrial Cancer Nicole Nevadunsky, MD   
A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer Rafi Kabarriti, MD   
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial Della Makower, MD   
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy Jana Fox, MD   
A Randomized Placebo Controlled Trial of IV Metoclopramide for Acute Post-traumatic Headache Benjamin Friedman, MD   
A Randomized, Crossover Phase 1 Study to Evaluate the Effects of Pevonedistat on the QTc Interval in Patients With Advanced Solid Tumors Sanjay Goel, MD   
A Randomized, Double-Blind, Placebo-Controlled Dose Ranging Study Evaluating Safety, Pharmacokinetics and Clinical Benefit of FLU-IGIV in Hospitalized Patients With Serious Influenza A Infection Paul Riska, MD   
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects With Extensive Stage Small Cell Lung Cancer (MERU) Balazs Halmos, MD   
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Pragmatic Clinical Trial To Evaluate The Effectiveness Of Low Dose Oral Methotrexate In Patients With Pediatric Crohn's Disease Initiating Anti-TNF Therapy (COMBINE) Gitit Tomer, MD   
A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Assess the Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis Steven Cohen, MD   
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder. Eric Hollander   
A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects With Resected Esophageal, or Gastroesophageal Junction Cancer (CheckMate 577) Lakshmi Rajdev, MD   
A randomized, open-label, multicenter, two arm, phase IIstudy to evaluate treatment compliance, efficacy and safety of an improved deferasirox formulation (granules) in pediatric patients with iron overload Deepa Manwani   
A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET) Benjamin Gartrell, MD   
A Randomized, Phase II Study Comparing Trastuzumab and Vinorelbine in Combination With Avelumab or Avelumab and Utomilumab (41BB/CD137 Agonist), in Patients With HER2-positive Metastatic Breast Cancer Who Have Progressed on Prior Trastuzumab and Pertuzum Sun Young Oh, MD   
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Nicole Nevadunsky, MD   
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy Jesus Anampa Mesias, MD   
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery Nitin Ohri, MD   
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy (POSITIVE) Joseph Sparano, MD   
A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (ARISE2) Michael Thorpy, MD   
A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults With Severe Sickle Cell Disease (BMT CTN #1503) Caterina Minniti, MD   
A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) (B-FAST) Haiying Cheng, MD   
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease Benjamin Gartrell, MD   
A Trial of Endocrine Response in Women With Invasive Lobular Breast Cancer Joseph Sparano, MD   
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer Benjamin Gartrell, MD   
Achieving Smoking Cessation Milestones in Opioid Treatment Patients: a Randomized 2 x 2 Factorial Trial of Directly Observed and Long-term Varenicline Shadi Nahvi, MD   
Adapting, Scaling, and Spreading an Algorithmic Asthma Mobile Intervention to Promote Patient-Reported Outcomes Within Primary Care Settings Sunit Jariwala, MD   
Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study Della Makower, MD   
Ambulatory Gynecologic Surgery: Finding the Optimal Postoperative Opioid Prescription Ja Hyun Shin, MD   
An ED-based Randomized Trial of IV Acetaminophen Versus IV Hydromorphone for Elderly Adults With Acute Severe Pain Alexander Latev, MD   
An ED-based Randomized Trial of IV Acetaminophen Versus IV Hydromorphone for Elderly Adults With Acute Severe Pain Alexander Latev, MD   
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease Kris Mahadeo   
An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors (RIFTOS MKI) Missak Haigentz, MD   
An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts Norman Medow, MD   
An Open Label, Phase 2 Pharmacokinetic Study of Pre-Surgical Intramuscular and Intraductal Fulvestrant in Women With Invasive Breast Cancer or DCIS Undergoing Mastectomy or Lumpectomy Sheldon Feldman, MD   
An Open-label, Multicenter Phase 1 Study to Characterize the Safety, Tolerability, Preliminary Antileukemic Activity, Pharmacokinetics, and Maximum Tolerated Dose or Pharmacological Active Dose of BAY2402234 in Patients With Advanced Myeloid Malignancies Amit Verma, MD   
An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) Benjamin Gartrell, MD   
An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery Sheldon Feldman, MD   
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID) Matthew Abramowitz, MD   
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) Matthew Abramowitz, MD   
Aneurysm Treatment Using the Heli-FX Aortic Securement System Global Registry (ANCHOR) Evan Lipsitz, MD   
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer: A Prospective Randomized Open Blinded End-Point (Probe) Study Henny Billett, MD   
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy (ADVANCE) Holly Kanavy, MD   
ARCHIVE: A registry for children with vasculitis: e-entry Maria Yee, MD   
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery Joseph Sparano, MD   
Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI) (VR Adult) Soo Yeon Kim, MD   
Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Pediatric Patients for Pain Control During Botox Injections for Spasticity Management: A Randomized Control Trial Yuxi Chen, MD   
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke (ARCADIA) Kathryn Kirchoff-Torres, MD   
Autism Genetics Network, Phase II: Increasing Representation of Human Diversity Sophie Molholm, PhD   
Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate Benjamin Gartrell, MD   
Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001) (MODIFY III) David Goldman, MD   
Breast Cancer WEight Loss Study (BWEL Study) Della Makower, MD   
Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma Lisa Gennarini, MD   
Buprenorphine Group Medical Visits for Drug Users at Risk for HIV Aaron Fox, MD   
Buprenorphine Treatment at Syringe Exchanges to Reduce Opioid Misuse and HIV Risk Aaron Fox, MD   
Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus Lakshmi Rajdev, MD   
Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) Eric Hollander, MD   
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF) Richard Lucariello, MD   
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer Joseph Sparano, MD   
Childhood Asthma Perception Study (CAPS) Jonathan Feldman, PhD   
Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT) Michael Thorpy, MD   
Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation (SOPRANO) Ulrich Jorde, MD   
COG-AALL0932 Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy) Lisa Figueiredo   
COG-AALL1131 A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND 73789, NSC 606869) in the Very High Risk Stratum Lisa Figueiredo   
COG-AAML1031 A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND114480 NSC 681239, NSC 724772) for Patients with High Allelic Ratio FLT3/ITD Lisa Figueiredo   
COG-ACCL1033 A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL Lisa Figueiredo   
COG-AEWS1031 A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma Lisa Figueiredo   
COG-ANBL00B1 Neuroblastoma Biology Studies Lisa Gennarini, MD   
COG-ANBL1232 Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma Lisa Figueiredo   
COG-ANHL12P1 A Randomized Phase II study of Brentuximab Vedotin (NSC 749710) and Crizotinib (NSC 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL) IND 117117 Jonathan Gill   
Cognitive Intervention to Improve Simple and Complex Walking Joe Verghese, MD   
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies Joseph Sparano, MD   
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations Lisa Gennarini, MD   
Combination Chemotherapy, Gemcitabine Hydrochloride, and Radiation Therapy Before Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer Lakshmi Rajdev, MD   
COMMUNITY CENTRAL LINE INFECTION PREVENTION (CCLIP) Trial Jennifer Davila   
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS: A Phase III Prospective Randomized Trial Sheldon Feldman, MD   
Consideration of Pedicle Screw Misplacement on a Per-Patient Basis: Can we Better Delineate Surgical Risk? Vishal Sarwahi, MD   
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) Haiying Cheng, MD   
Defensin and Innate Mucosal Immune Mediator Expression in Pediatric Inflammatory Bowel Disease Gitit Tomer, MD   
Desmopressin as a Therapy for Nocturnal Enuresis in Patients with Sickle Cell Disease Kerry Morrone   
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States Olga Derman, MD   
Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy (NICMR) Mario Garcia, MD   
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM Lisa Underland, MD   
Does Pedicle Morphology Change with Age? Vishal Sarwahi, MD   
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Della Makower, MD   
Effect of Randomization to Neuromuscular Blockade on Physical Functional Impairment and Recovery in ARDS Aluko Hope, MD   
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) Balazs Halmos, MD   
Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome: Utility of Plasma Zonulin Levels as a Predictive Biomarker Frederick Kaskel, MD   
Efficacy of Silicone Gel Versus Placebo for Postsurgical Scars of the Eyelid Anne Barmettler, MD   
EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FORTREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHICARTHRITIS (JIA) IN CHILDREN AND ADOLESCENT SUBJECTS Dawn Wahezi   
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial Joseph Sparano, MD   
Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients Marina Reznik   
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study) Jacqueline Lamour, MD   
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) Haiying Cheng, MD   
EVALUATING THE BENEFIT OF CONCURRENT TRICUSPID VALVE REPAIR DURING MITRAL SURGERY Robert Michler, MD   
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug- Eluting StEnts The ECLIPSE Trial Giora Weisz, MD   
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) Anne Van Arsdale, MD   
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery Steven Libutti, MD    
Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic Della Makower, MD    
Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy Michael Thorpy, MD   
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer Sanjay Goel, MD   
FIRSTx - A Phase 2 Multicenter, Open Label, Randomized Study of Two Titration Regimens of Oral CXA-10 in Subjects With Primary Focal Segmental Glomerulosclerosis (FSGS) Tanya Johns, MD   
FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer (FLT3) Nitin Ohri, MD   
Follow-up study of children with early diagnosis of autism spectrum disorder Lisa Shulman, MD   
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery Della Makower, MD    
Gene Discoveries in Subjects with Crohns Disease of African Descent Gitit Tomer, MD   
Genetic Predisposition to Appendicitis: A Pilot Study Dominique Jan, MD   
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) Steven Keller, MD   
Global Congestive Heart Failure (G-CHF) Study: A Global Registry to Study the Demographics, Socioeconomic and Clinical Factors, Etiologies, Pathophysiology, Management, Barriers to Care, and Outcomes of Heart Failure Patients Ileana Pina, MD   
HEALTHCALL ENHANCING BRIEF INTERVENTION FOR HIV PRIMARY CARE ALCOHOL DEPENDENCE Barry Zingman, MD   
Hematology Biobank : Invitro Study of Blood Disorders Henny Billett, MD   
High Risk Multiple Gestation Study Peer Dar, MD   
Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial Deepa Manwani, MD   
Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD) (INTEGRATE) Olga Derman, MD   
Immediate postpartum contraceptive implant placement and breastfeeding success in women at risk for low milk supply a randomized non-inferiority trial Erika Levi, MD   
Implementation of a Prospective Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer Sanjay Goel, MD   
Infantile Spasms Multicenter Database Elissa Yozawitz, MD   
Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers Study (INSIGHTS Study) Caterina Minniti, MD   
International Registry for Severe Chronic Neutropenia Kerry Morrone, MD   
Intravenous Gammaglobulin for Sickle Cell Pain Crises Deepa Manwani, MD   
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects Giles Peek, MD   
LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT-SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TOPULMONARY VEIN ISOLATION FOR PERSISTENT ORLONGSTANDING PERSISTENT ATRIAL FIBRILLATION Luigi Di Biase, MD, PhD   
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens Heather Smith, MD   
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers Golda Hudes, MD   
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Haiying Cheng, MD   
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma Lisa Gennarini, MD   
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial Nitin Ohri, MD   
MarginProbe® System U.S. Post-Approval Study Protocol CP-07-001 Sheldon Feldman, MD   
Matched Targeted Therapy (MTT) Recommendation for Patients with Recurrent, Refractory, or High Risk Leukemias Lisa Gennarini, MD   
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases William Bodner, MD   
Metformin in Children With Relapsed or Refractory Solid Tumors Daniel Weiser, MD   
Modifiers of PrEP Efficacy Impact of the Vaginal Microbiome and Age Marla Keller, MD   
Molecular and Genomic Profiling of Head and Neck Tumors Richard Smith, MD   
Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction Mamta Fuloria, MD   
Monitoring Neoadjuvant Chemotherapy Response In Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging (DOSI) Bang Hoang, MD   
Montefiore Opioid and Pain Study (MOPS) Benjamin Friedman, MD   
Mood disorder and cognitive dysfunction in pediatric lupus Chaim Putterman, MD   
Motor Imagery A Pilot Intervention for Improving Gait and Cognition in the Elderly Helena Blumen, MD   
Multicenter Cohort Study To Evaluate Outcomes After Receipt of Targeted Therapy Matched to an Individualized Cancer Therapy (iCat) Recommendations in Children and Young Adults With Solid Tumors: The iCat2, GAIN Consortium Study Daniel Weiser, MD   
Multicenter Expanded Access Protocol of Allogeneic Epstein-Barr Virus Cytotoxic T Lymphocytes (EBV-CTLs) for Patients with EBV-Associated Viremia or Malignancies for Whom there are No Appropriate Alternative Therapies Lisa Figueiredo   
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease (IPSG1) Eric Fornari, MD   
Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE) David Loeb, MD   
Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE) Ioannis Mantzaris, MD   
Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors Sanjay Goel, MD   
Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab (MATCH Study) David Loeb, MD   
Multicultural Healthy Diet to Reduce Cognitive Decline & Alzheimer's Disease Risk Yasmin Mossavar-Rahmani, MD   
Myocardial Ischemia and Transfusion Mark Menegus, MD   
Natural History Study of the Development of Type 1 Diabetes Lisa Underland, MD   
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas Balazs Halmos, MD   
Nephrotic Syndrome Study Network Under the Rare Diseases Clinical Research Network (NEPTUNE) Frederick Kaskel, MD   
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Lisa Gennarini, MD   
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (ANVIL) Haiying Cheng, MD   
Nivolumab and Ipilimumab in Treating Patients With Advanced HIV Associated Solid Tumors Lakshmi Rajdev, MD   
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) Arye Rubinstein, MD   
Noninvasive Monitoring of Uterine Electrical Activity and Fetal Heart Rate: A New External Monitoring Device Peter Bernstein, MD   
North American Pediatric Renal Trials and Collaborative Studies Marcela Del Rio, MD   
Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF) Meredith Hawkins, MD   
NRG-GI002 A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer Rafi Kabarriti, MD   
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) (TRUMPET) Benjamin Gartrell, MD    
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry Yonit Sterba Ruas, MD   
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer (OlympiA) Jesus Anampa Mesias, MD    
Omega-3 Replacement With Krill Oil in Disease Management of SLE (ORKIDS) Chaim Putterman, MD   
Open-label, Phase I/II Study to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Anticancer Activity of Avelumab in Pediatric Subjects From Birth to Less Than 18 Years of Age With Refractory or Relapsed Solid Tumors and Lymphoma David Loeb, MD   
OPtical Coherence Tomography (OCT) Guided Coronary Stent IMplantation Compared to Angiography: a Multicenter Randomized TriaL in PCI Giora Weisz, MD   
Outcomes of Neonatal Acute Kidney Injury In Premature Infants Mamta Fuloria, MD   
Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations (PREPARE) Melissa Mckee, MD   
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI) Joseph Sparano, MD   
Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Randomized Trial Comparing Two Radiotherapy Schedules Nitin Ohri, MD   
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Benjamin Gartrell, MD    
PC4PrEP: Integrating Pre-Exposure Prophylaxis (PrEP) Into Primary Care Laurie Bauman, MD   
Ped Cardiac Quality of LIfe Jacqueline Lamour, MD   
Pediatric Heart Transplant Study Group Jacqueline Lamour, MD   
Peer Mentor Training to Reduce Hospitalizations for Children With Asthma Deepa Rastogi, MD   
Peer Mentorship to Improve Outcomes in Patients on Maintenance Hemodialysis Ladan Golestaneh, MD   
PERL (Preventing Early Renal Loss in Diabetes) Continuous Glucose Monitoring (CGM) Study Jill Crandall, MD   
Personalized Medicine: Pediatric Total Cancer Care™ Protocol Daniel Weiser, MD   
Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD) Anna Zolotnitskaya, MD   
Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Adult Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC) Deepa Manwani, MD   
Phase 1/2 Study of Vactosertib (TEW-7197) Monotherapy in Patients With Low or Intermediate Myelodysplastic Syndromes Amit Verma, MD   
Phase 1/2, First-in-Human, Dose-Escalation Study of X-396 in Patients With Advanced Solid Tumors and Expansion Phase in Patients With ALK-positive Non-Small Cell Lung Cancer Haiying Cheng, MD   
Phase 1/2, Multicenter, Open-label, Multiple-Dose First-in-human Study of U3-1402, in Subjects With HER3 Positive Metastatic Breast Cancer Sun Young Oh, MD   
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy (OPUS) Alexis Boro, MD   
Phase 2 Multi-center Study of Pembrolizumab in Combination With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation and ALK Positive NSCLC (Non-Small Cell Lung Cancer) w/Progressive Disease Following Prior Tyrosine Kinase Inhibitors (TKIs) Balazs Halmos, MD   
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2 Breast Carcinoma Sun Young Oh, MD   
Phase 2 Study of Denosumab (IND 127430, NSC 744010), a Rank Ligand Antibody, for Recurrent or Refractory Osteosarcoma Lisa Figueiredo   
Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Children and Adolescents With Prader-Willi Syndrome Eric Hollander, MD   
Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 20 mg or 14 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Missak Haigentz, MD   
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer Sanjay Goel, MD   
PHASE 3 STUDY OF IV TO ORAL 6-DAY TEDIZOLID PHOSPHATE COMPARED WITH 10-DAY COMPARATOR IN SUBJECTS 12 TO David Goldman   
Phase I and Dose-Expansion Study of Ibrutinib and R-da-EPOCH for Front Line Treatment of AIDS-Related Lymphomas Ioannis Mantzaris, MD   
Phase I TITE-CREM Dose Escalation Study of Fractionated Stereotactic Radiation Therapy (FSRT) in Unresected Brain Metastases Madhur Garg, MD   
Phase I/II Trial of Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer Della Makower, MD    
Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Benjamin Gartrell, MD   
Phase Ib/II Study of Concurrent Durvalumab And Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder: Big Ten Cancer Research Consortium BTCRC-GU15-023 Alexander I. Sankin, MD   
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing Balazs Halmos, MD   
Phase II Study of Lenalidomide and Eltrombopag in Patients with Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome Amit Verma, MD   
Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC)(KEYNOTE-199) Benjamin Gartrell, MD   
Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers Caterina Minniti, MD   
Phase II Trial Testing the Antiemetic Efficacy of a Single-day Low Dose Aprepitant (or Fosaprepitant) Added to a 5-HT3 Receptor Antagonist Plus Dexamethasone in Patients Receiving Carboplatin Richard Gralla, MD   
Phase III Multicenter Open-label Randomized Clinical Trial Comparing Everolimus and Low Dose Tacrolimus to Tacrolimus and Mycophenolate Mofetil at 6 mo Post-Transplant to Prevent Long-term Complications After Pediatric Heart Transplantation Jacqueline Lamour, MD   
Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation Benjamin Gartrell, MD   
Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Patients With ER+/HER2- Metastatic Breast Cancer Jesus Anampa Mesias, MD   
Pilot Study of Adoptive Cell Transfer for the Treatment of Metastatic Cancer that Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 Murine TCR-Gene Engineered Lymphocytes Ira Braunschweig, MD   
Platinum Based Chemotherapy or Observation in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy Joseph Sparano, MD   
Prediction of Functional Outcomes From Chronic Critical Illness Aluko Hope, MD   
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE) Joseph Sparano, MD   
Problem Adaptation Therapy for Mild Cognitive Impairment and Depression Mirnova Ceide, MD   
Project: Every Child for Younger Patients With Cancer Lisa Gennarini, MD   
Promoting Asthma Guidelines and Management through Technology-Based Intervention and Care Coordination (PRAGMATIC) Marina Reznik, MD   
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center International Randomized Controlled Trial Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections With Endoprosthetic Replacements David Geller, MD   
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Rebecca Levine, MD    
Prospective Randomized Control Trial Evaluating Single Shot Exparel Versus Indwelling Interscalene Catheter for Total Shoulder Replacements- A Pilot Study Elilary Montilla Medrano, MD   
Prospective, Multi Centre, International Registry of Male and Female Patients Newly Diagnosed With Atrial Fibrillation Kevin Ferrick, MD   
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries Ira Braunschweig, MD   
Protocol for a Research Sample Repository and for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies, and Marrow Toxic Injuries David Loeb, MD   
Protocol for a Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation Ira Braunschweig, MD   
Quarenta Semanas: Innovative Intervention in Prenatal Care for Reduction of Prematurity (quarenta) Judy Aschner, MD   
Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With High-risk Endometrial Cancer Dennis Kuo, MD   
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can be Removed by Surgery (PAZNTIS) Lisa Gennarini, MD   
Randomized Clinical Trial of IV Acetaminophen as an Adjuvant Analgesic to IV Hydromorphone for Treatment of Acute Severe Pain in Non-Elderly Emergency Department Patients Polly Bijur, MD   
Randomized On-X Anticoagulation Trial Ricardo Bello, MD   
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA) Madhur Garg, MD   
Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC 750008, IND 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma Lisa Figueiredo   
Randomized Phase II/III Study of Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women w/Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Nicole Nevadunsky, MD   
Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC) (An ALCHEMIST Treatment Trial) Haiying Cheng, MD   
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention Joseph De Rose, MD   
Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer Jesus Anampa Mesias, MD   
Reevaluation Of Systemic Early Neuromuscular Blockade (ROSE) Michelle Gong, MD   
Registry of Guardant360® Use and Outcomes In People With Advanced Cancer Balazs Halmos, MD   
Regulation of Endogenous Glucose Production by Central KATP Channels Meredith Hawkins, MD   
RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure Giora Weisz, MD   
Reproductive Health Program in Patients With Cancer Della Makower, MD    
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma Peter Cole, MD   
Restorelle® Mesh Versus Native Tissue Repair for Prolapse Keith Downing, MD    
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Peter Cole, MD   
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) Lisa Gennarini, MD   
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction Jana Fox, MD   
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3) Della Makower, MD    
S1314, A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer Benjamin Gartrell, MD   
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer (COXEN) Benjamin Gartrell, MD    
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Lakshmi Rajdev, MD   
Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry (SABLE) Chaim Putterman, MD   
Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers Rafi Kabarriti, MD   
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery Stuart Greenstein, MD   
Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer Sun Young Oh, MD   
Safety Follow-up Through 180 Days of Treatment withRemestemcel-L in Study MSB-GVHD001 in Pediatric Patients who have Failed to Respond to Steroid Treatment for Acute GVHD Deepa Manwani   
Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome Amit Verma, MD   
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant Kris Mahadeo, MD   
Self regulation in children with learning disabilities and inattention/hyperactivity Katherine Lawson, PhD   
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness Sophie Molholm, PhD   
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads Nils Guttenplan, MD   
Simple Bone Cysts in Kids (SBoCK) Jacob Schulz, MD   
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C Haejin In, MD   
Single-dose Intraoperative Methadone for Early Ambulation and Sustained Pain Control in Spinal Fusion Surgery Patients Merritt Drew Kinon, MD   
Social Dancing Intervention for Older Adults at High Risk of Alzheimer's Disease and Other Dementias: A Pilot Study Joe Verghese, MD   
Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Michael Thorpy, MD   
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer Nitin Ohri, MD   
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Jana Fox, MD   
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918) (SMARTMSP) Luigi Di Biase, MD, PhD   
Study of Acarbose in Longevity Erika Brutsaert, MD   
Study of Allogeneic EBV-CTLs in EBV-Associated Viremia or Malignancies Murali Janakiram, MD   
Study of Allogeneic EBV-CTLs in EBV-Associated Viremia or Malignancies David Loeb, MD   
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer (MAINTAIN) Sun Young Oh, MD   
Study of Kidney Tumors in Young Patients Lisa Gennarini, MD   
Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia Scott Aydin,MD   
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer Lisa Gennarini, MD   
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] Steven Keller, MD   
Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients Enver Akalin, MD   
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) Balazs Halmos, MD   
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis Dana Lukin, MD   
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer Jana Fox, MD   
Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC) Peter Muscarella, MD   
Technology-Assisted Weight Management Intervention Within Patient-Centered Medical Homes: The GEM (Goals for Eating and Moving) Study Judith Wylie-Rosett, MD   
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Mary Welch, MD   
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men (Alliance A191402CD) Evan Kovac, MD   
The ASTHMA-Educator: A novel Algorithmic Software Tool in the Healthcare system for Managing Asthma Sunit P. Jariwala, MD   
The Children’s Spine Registry Jaime Gomez, MD   
The Chimerix CMX001 Registry Olga Derman, MD   
The Comparison Study of Virtual Reality Rehabilitation With Standard Occupational Therapy Versus Standard Occupational Therapy Gary Inwald, MD   
The Effect of AposTherapy on Pain and Function in a Non Specific Low Back Pain Population. A Randomized Controlled Trial Matthew Bartels, MD   
The Effect of AposTherapy on Pain and Function in Knee Osteoarthritis Population: A Randomized Controlled Trial Matthew Bartels, MD   
The Effect of Footwear Generated Biomechanical Manipulation on Symptoms of Stress Urinary Incontinence: A Randomized Controlled Trial Anna Lasak, MD   
The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy Rouzan Karabakhtsian, MD   
The Influence of Breakfast on Hormone Responses and Cognitive Performance, as Assessed by CTET in Lean and Obese Adolescent Males Lisa Underland, MD   
The National Emergency Airway Registry for Children Michael Miksa, MD   
The National Myelodysplastic Syndromes Natural History Study Aditi Shastri, MD   
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study (OPTIMIZE) Giora Weisz, MD   
The Reliability of X-Ray Based Evaluation of Pedicle Screw Misplacement in Adolescent Spinal Deformity Vishal Sarwahi, MD   
The Role of Hemolysis in Promoting Thrombosis During Mechanical Circulatory Support With Continuous Flow Pumps Omar Saeed, MD   
The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients Meredith Hawkins, MD   
The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial (SPRINT) Nitin Ohri, MD   
The use of Complementary and Alternative Medicine in Autism Maria Valicenti-McDermott, MD    
The Use of Lumbar Erector Spinae Plane Block for Hip Arthroplasty at the L4 Interspace- a Randomized Controlled Study Comparing the 24-hour Opioid Requirements Iyabo Muse, MD   
The use of Virtual Reality Games to Enhance Therapy for Children with Cerebral Palsy. A pilot Study Maria Valicenti-McDermott, MD    
Therasphere for Unresectable Primary or Secondary Liver Neoplasia Renee Moadel, MD   
TMEM-MRI: A Pilot Feasibility Study of Magnetic Resonance Imaging for Imaging of TMEM (Tumor Microenvironment of Metastasis) in Patients With Operable Breast Cancer Jesus Anampa Mesias, MD   
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (TRIPLE) John Hardin   
Tomosynthesis Mammographic Imaging Screening Trial (TMIST) Beatriu Reig, MD   
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions (ANCHOR) Rebecca Levine, MD   
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Missak Haigentz, MD   
Transthyretin-Associated Amyloidosis Outcomes Survey (THAOS) A Global, Multi-Center, Longitudinal, Observational Survey of Patients With Documented Transthyretin (TTR) Mutations or Wild-Type TTR Amyloidosis James Tauras, MD   
Treatment of Breast Fibroadenoma Targeted Tissue With High Intensity Focused Ultrasound (HIFU) Sheldon Feldman, MD   
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents Lisa Gennarini, MD   
US-based, Observational, Drug Registry of Opsumit® (Macitentan) New Users in Clinical Practice Sandhya Murthy, MD   
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide Meredith Hawkins, MD   
Use of Perioperative Antibiotics in Endoscopic Sinus Surgery Nadeem Akbar, MD   
VALENS: A Ph 1/2, Random'd, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate Safety/Preliminary Efficacy of AT342, an AAV8-Delivered Gene Transfer Therapy in Crigler-Najjar Syndrome Subjects Aged 1 Yr and Older Nadia Ovchinsky, MD   
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Sanjay Goel, MD   
Web-based Peer Mentor Training to Reduce Hospitalizations for Children with Asthma Deepa Rastogi, MD   
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer William Bodner, MD